TrianglePUBLICATIONS · 24115731
Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2014 Mar
- First author
- Shukla N
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Shukla N
- type
- Author
- name
- Kobos R
- type
- Author
- name
- Renaud T
- type
- Author
- name
- Steinherz LJ
- type
- Author
- name
- Steinherz PG
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Shukla N
- type
- Author
- name
- Kobos R
- type
- Author
- name
- Renaud T
- type
- Author
- name
- Steinherz LJ
- type
- Author
- name
- Steinherz PG
- type
- Author
- bibliography ids
- nci-bib-138a21ce765c34fed47ff336
- book metadata
- content sha256
- daf3fbb21f2e9be86e510c7748d16490ad34bdb6df1ed53a13a01806c75eac1b
- document type
- citation
- dois
- 10.1002/pbc.24789
- electronic publication date
- display
- 2013 Sep 24
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:24115731
- immutable id
- pubmed:24115731@daf3fbb21f2e9be86e510c7748d16490ad34bdb6df1ed53a13a01806c75eac1b
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 3
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- 431-5
- volume
- 61
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 24115731
- provenance
- batch id
- 0a08f044391426feb8ef
- provider
- NCBI PubMed ESummary
- record sha256
- eeecf8f0b72d6072ff0e0e9d4b24f3464463f5f186feb6d36209aaa0d1bd3f30
- response sha256
- d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
- retrieved at
- 2026-09-09T23:46:57.614689+00:00
- publication date
- display
- 2014 Mar
- precision
- month
- year
- 2014
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia.
Preserved source evidence · Not medical advice